Vectibix User Reviews & Ratings
Vectibix has an average rating of 7.0 out of 10 from a total of 4 reviews on Drugs.com. 75% of reviewers reported a positive experience, while 25% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Colorectal Cancer | 4 reviews for Colorectal Cancer | 31 medications |
- Anonymous
- Taken for 1 to 6 months
- November 8, 2017
For Colorectal Cancer "This medication has my carcinoembryonic antigen (CEA) test numbers way down. I hate the rash, but at least I'm alive."
- Anonymous
- Taken for 1 to 6 months
- December 27, 2017
For Colorectal Cancer "Have been on this since 8-2017, and my CEA marker is down from 16.1 to 3.6. The side effect of dry skin is tolerable."
- Gle...
- March 29, 2016
For Colorectal Cancer "It's bad enough to have cancer, but this drug doesn't work and turns patients into lepers."
See also:
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about Vectibix (panitumumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
For Colorectal Cancer "Vectibix reduced my CEA (cancer marker) from 25.2 all the way down to 2.5 within the matter of a few months. The skin reaction sucks. Thankfully, I am able to undergo a revolutionary surgery to remove the portion of my liver with the metastatic cancer, so I have just recently been able to stop the Vectibix. I am hoping I will get my beautiful skin back."